RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 11.5935

Change

-0.13 (-1.08)%

Market Cap

N/A

Volume

4.21K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

-0.44 (-1.06%)

USD 0.89B
SOXS Direxion Daily Semiconductor B..

-0.60 (-2.89%)

USD 0.73B
PSQ ProShares Short QQQ

-0.47 (-1.29%)

USD 0.51B
SPXU ProShares UltraPro Short S&P50..

-0.69 (-3.21%)

USD 0.50B
SDOW ProShares UltraPro Short Dow30

-1.21 (-2.45%)

USD 0.26B
YANG Direxion Daily FTSE China Bear..

-2.32 (-3.42%)

USD 0.16B
SPDN Direxion Daily S&P 500® Bear ..

-0.12 (-1.06%)

USD 0.14B
RWM ProShares Short Russell2000

-0.16 (-0.86%)

USD 0.14B
DOG ProShares Short Dow30

-0.22 (-0.84%)

USD 0.13B
DUST Direxion Daily Gold Miners Ind..

-0.03 (-0.04%)

USD 0.11B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.82% 95% A 28% F
Dividend Return 3.50% 64% D 52% F
Total Return 0.67% 93% A 27% F
Trailing 12 Months  
Capital Gain -4.11% 91% A- 26% F
Dividend Return 3.45% 62% D 51% F
Total Return -0.66% 89% A- 25% F
Trailing 5 Years  
Capital Gain -65.96% 72% C 6% D-
Dividend Return 2.67% 64% D 7% C-
Total Return -63.29% 70% C- 5% F
Average Annual (5 Year Horizon)  
Capital Gain 62.33% 40% F 95% A
Dividend Return 63.48% 40% F 95% A
Total Return 1.15% 57% F 28% F
Risk Return Profile  
Volatility (Standard Deviation) 433.95% 62% D 3% F
Risk Adjusted Return 14.63% 45% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.